Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Weg-Remers

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Der Radiologe|September 6, 2014
[The cancer information service of the German Cancer Research Center]S Weg-Remers
Annals of the New York Academy of Sciences|December 18, 2002
Antagonistic signaling pathways regulate alternative splicing of CD44 in T cellsS Weg-Remers, H Ponta, P Herrlich, et al.
Annals of the New York Academy of Sciences|February 3, 1999
CD44 expression in colorectal cancerS Weg-Remers, G Schüder, M Zeitz, et al.
The EMBO Journal|August 3, 2001
Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathwayS Weg-Remers, H Ponta, P Herrlich, et al.
Der Radiologe|July 1, 1996
[Arterioportal fistulas in the extra-hepatic circulation of the common hepatic artery. Diagnosis and radiologic interventional therapy]J Klinkner, R Kubale, D Hu, et al.
The Journal of Biological Chemistry|August 26, 2000
Heterogeneous ribonucleoprotein A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathwaysN Matter, M Marx, S Weg-Remers, et al.
Endoscopy|November 24, 1998
Esophageal involvement in cicatricial pemphigoidA Stallmach, S Weg-Remers, C Moser, et al.
The American Journal of Gastroenterology|June 13, 1998
Soluble CD44 and CD44v6 serum levels in patients with colorectal cancer are independent of tumor stage and tissue expression of CD44v6S Weg-Remers, U Hildebrandt, G Feifel, et al.
Annals of the New York Academy of Sciences|July 27, 2000
CD44 acts both as a growth- and invasiveness-promoting molecule and as a tumor-suppressing cofactorP Herrlich, H Morrison, J Sleeman, et al.
Experimental and Molecular Pathology|March 27, 2001
Stage-specific alternative cplicing of CD44 and alpha 6 beta 1 integrin in colorectal tumorigenesisB M Wittig, R Goebel, S Weg-Remers, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Der Radiologe|September 6, 2014
[The cancer information service of the German Cancer Research Center]S Weg-Remers
Annals of the New York Academy of Sciences|December 18, 2002
Antagonistic signaling pathways regulate alternative splicing of CD44 in T cellsS Weg-Remers, H Ponta, P Herrlich, et al.
Annals of the New York Academy of Sciences|February 3, 1999
CD44 expression in colorectal cancerS Weg-Remers, G Schüder, M Zeitz, et al.
The EMBO Journal|August 3, 2001
Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathwayS Weg-Remers, H Ponta, P Herrlich, et al.
Der Radiologe|July 1, 1996
[Arterioportal fistulas in the extra-hepatic circulation of the common hepatic artery. Diagnosis and radiologic interventional therapy]J Klinkner, R Kubale, D Hu, et al.
The Journal of Biological Chemistry|August 26, 2000
Heterogeneous ribonucleoprotein A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathwaysN Matter, M Marx, S Weg-Remers, et al.
Endoscopy|November 24, 1998
Esophageal involvement in cicatricial pemphigoidA Stallmach, S Weg-Remers, C Moser, et al.
The American Journal of Gastroenterology|June 13, 1998
Soluble CD44 and CD44v6 serum levels in patients with colorectal cancer are independent of tumor stage and tissue expression of CD44v6S Weg-Remers, U Hildebrandt, G Feifel, et al.
Annals of the New York Academy of Sciences|July 27, 2000
CD44 acts both as a growth- and invasiveness-promoting molecule and as a tumor-suppressing cofactorP Herrlich, H Morrison, J Sleeman, et al.
Experimental and Molecular Pathology|March 27, 2001
Stage-specific alternative cplicing of CD44 and alpha 6 beta 1 integrin in colorectal tumorigenesisB M Wittig, R Goebel, S Weg-Remers, et al.
Pageof 2